Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice Detti

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Expert Review of Anticancer Therapy|May 21, 2025
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancerGianluca Ingrosso, Andrea Lancia, Lilia Bardoscia, et al.
Critical Reviews in Oncology/Hematology|December 11, 2020
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgerySilvia Scoccianti, Marco Perna, Emanuela Olmetto, et al.
La Radiologia Medica|November 8, 2021
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysisMaurizio Valeriani, Beatrice Detti, Andrei Fodor, et al.
La Radiologia Medica|August 19, 2023
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysisGiulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2023
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO)Giulio Francolini, Andrea Gaetano Allegra, Beatrice Detti, et al.
Future Oncology (London, England)|March 10, 2016
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experienceIcro Meattini, Isacco Desideri, Vanessa Di Cataldo, et al.
Cancer|March 22, 2022
Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient-level data from 4 prospective trialsHaley K Perlow, Rahul N Prasad, Mike Yang, et al.
Medical Oncology (Northwood, London, England)|May 19, 2021
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistanceLuca Triggiani, Rosario Mazzola, Davide Tomasini, et al.
Cancers|June 2, 2021
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO)Ercole Mazzeo, Luca Triggiani, Luca Frassinelli, et al.
La Radiologia Medica|September 20, 2023
Stereotactic reirradiation with Cyberknife<sup>R</sup> for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohortGiulio Francolini, Maria Grazia Carnevale, Vanessa Di Cataldo, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Expert Review of Anticancer Therapy|May 21, 2025
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancerGianluca Ingrosso, Andrea Lancia, Lilia Bardoscia, et al.
Critical Reviews in Oncology/Hematology|December 11, 2020
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgerySilvia Scoccianti, Marco Perna, Emanuela Olmetto, et al.
La Radiologia Medica|November 8, 2021
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysisMaurizio Valeriani, Beatrice Detti, Andrei Fodor, et al.
La Radiologia Medica|August 19, 2023
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysisGiulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2023
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO)Giulio Francolini, Andrea Gaetano Allegra, Beatrice Detti, et al.
Future Oncology (London, England)|March 10, 2016
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experienceIcro Meattini, Isacco Desideri, Vanessa Di Cataldo, et al.
Cancer|March 22, 2022
Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient-level data from 4 prospective trialsHaley K Perlow, Rahul N Prasad, Mike Yang, et al.
Medical Oncology (Northwood, London, England)|May 19, 2021
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistanceLuca Triggiani, Rosario Mazzola, Davide Tomasini, et al.
Cancers|June 2, 2021
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO)Ercole Mazzeo, Luca Triggiani, Luca Frassinelli, et al.
La Radiologia Medica|September 20, 2023
Stereotactic reirradiation with Cyberknife<sup>R</sup> for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohortGiulio Francolini, Maria Grazia Carnevale, Vanessa Di Cataldo, et al.
Pageof 12